These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32710648)

  • 21. Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.
    Fortanier E; Delmont E; Verschueren A; Attarian S
    Clin Neurophysiol; 2020 May; 131(5):1129-1133. PubMed ID: 32217467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute-onset chronic inflammatory demyelinating polyneuropathy: An electrodiagnostic study.
    Anadani M; Katirji B
    Muscle Nerve; 2015 Nov; 52(5):900-5. PubMed ID: 25809534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum levels of endothelin-1 in patients with chronic inflammatory demyelinating polyneuropathy.
    Chang CW; Wu HC; Lyu RK; Lo YS; Chen CM; Ro LS; Chang HS; Huang CC; Liao MF; Wu YR; Kuo HC; Chu CC; Weng YC; Wei PT; Lo AL; Chang KH
    Clin Chim Acta; 2018 Jan; 476():49-53. PubMed ID: 29137897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease activity in chronic inflammatory demyelinating polyneuropathy.
    Albulaihe H; Alabdali M; Alsulaiman A; Abraham A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    J Neurol Sci; 2016 Oct; 369():204-209. PubMed ID: 27653889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Kacar A; Bjelica B; Bozovic I; Peric S; Nikolic A; Cobeljic M; Petrovic M; Stojanov A; Djordjevic G; Vukojevic Z; Dominovic-Kovacevic A; Stojanovic M; Stevic Z; Rakocevic-Stojanovic V; Lavrnic D; Basta I
    J Peripher Nerv Syst; 2018 Mar; 23(1):11-16. PubMed ID: 29360221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of social-functioning and sleep on quality of life in chronic inflammatory demyelinating polyneuropathy.
    Englezou C; Nazeer KK; Rajabally YA
    Clin Neurol Neurosurg; 2023 Nov; 234():108017. PubMed ID: 37866209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy.
    Lucke IM; Wieske L; van der Kooi AJ; van Schaik IN; Eftimov F; Verhamme C
    J Peripher Nerv Syst; 2019 Jun; 24(2):174-179. PubMed ID: 31090121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany.
    Mengel D; Fraune L; Sommer N; Stettner M; Reese JP; Dams J; Glynn RJ; Balzer-Geldsetzer M; Dodel R; Tackenberg B
    Muscle Nerve; 2018 Nov; 58(5):681-687. PubMed ID: 30073683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic Inflammatory Demyelinating Polyneuropathy.
    Kuwabara S; Misawa S
    Adv Exp Med Biol; 2019; 1190():333-343. PubMed ID: 31760654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor unit number index (MUNIX) in chronic inflammatory demyelinating polyneuropathy: A potential role in monitoring response to intravenous immunoglobulins.
    Lawley A; Seri S; Rajabally YA
    Clin Neurophysiol; 2019 Oct; 130(10):1743-1749. PubMed ID: 31400577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
    De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
    J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy.
    Dionne A; Nicolle MW; Hahn AF
    Muscle Nerve; 2010 Feb; 41(2):202-7. PubMed ID: 19882646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin.
    Ryltoft AK; Al-Zuhairy A; Sindrup SH; Andersen H; Markvardsen LK
    Acta Neurol Scand; 2020 Dec; 142(6):637-640. PubMed ID: 33404110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg.
    Caro XJ; Winter EF; Dumas AJ
    Rheumatology (Oxford); 2008 Feb; 47(2):208-11. PubMed ID: 18208823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
    Nasu S; Misawa S; Sekiguchi Y; Shibuya K; Kanai K; Fujimaki Y; Ohmori S; Mitsuma S; Koga S; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffusion tensor imaging can be used to detect lesions in peripheral nerves in patients with chronic inflammatory demyelinating polyneuropathy treated with subcutaneous immunoglobulin.
    Markvardsen LH; Vaeggemose M; Ringgaard S; Andersen H
    Neuroradiology; 2016 Aug; 58(8):745-52. PubMed ID: 27114080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term and long-term effects of immunoadsorption in refractory chronic inflammatory demyelinating polyneuropathy: a prospective study in 17 patients.
    Dorst J; Ludolph AC; Senel M; Tumani H
    J Neurol; 2018 Dec; 265(12):2906-2915. PubMed ID: 30293110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic inflammatory demyelinating polyneuropathy: quality of life, sociodemographic profile and physical complaints.
    Santos PL; Almeida-Ribeiro GA; Silva DM; Marques Junior W; Barreira AA
    Arq Neuropsiquiatr; 2014 Mar; 72(3):179-83. PubMed ID: 24676433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease Activity.
    Stascheit F; Hotter B; Klose S; Meisel C; Meisel A; Klehmet J
    Front Neurol; 2021; 12():723009. PubMed ID: 34589050
    [No Abstract]   [Full Text] [Related]  

  • 40. Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy.
    Harbo T; Andersen H; Overgaard K; Jakobsen J
    J Peripher Nerv Syst; 2008 Sep; 13(3):208-17. PubMed ID: 18844787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.